PharmaTimes -
December

Compared to other world events, pharma's 2016 has been relatively calm – but that doesn't mean that this year hasn't brought significant changes for the industry.

In our Review of 2016 (p23), we round up all the most important issues of the year for the industry and add some expert analysis to help you prepare for 2017. Political upheaval, innovation in the NHS, the growth of biosimilars and big changes to market access have all forced pharma to rethink its strategy for the next few years – but as the industry's position on these solidifies we can at least say that it should be be tackling them from a position of strength. 

After all, these issues are only going to continue into 2017 – as shown by our SmartViews pieces on the NHS' drive to improve mental health services (Thinking alike, p17) and NICE's new rules (A new way in, p20), as well as our feature on the downsides of minimising drug prices (The bigger picture, p38).

December 2016 - magazine highlights

Thumbnail image for The bigger picture

The bigger picture

Delivering the maximum possible benefits to the NHS does not necessarily mean minimising prices, finds a new report

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download